Product
IFN-γ
1 clinical trial
3 indications
Indication
Myelodysplastic SyndromesIndication
Myeloid LeukemiaIndication
Allogeneic Stem Cell TransplantationClinical trial
A Pilot Study of IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2023-10-30